Reports of 5-ASA-associated pancreatitis from the FDA adverse event reporting databases

被引：0
|
作者：
Ruggieri, Alexander P.
Kanumalla, Anju
Watson, John F.
机构：
来源：
GASTROENTEROLOGY | 2007年 / 132卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A343 / A343
页数：1
相关论文
共 50 条
  • [31] Aplastic anemia associated with osimertinib: Analysis of the FDA adverse event reporting system
    Ohyama, Katsuhiro
    Katagiri, Seiichiro
    Takahashi, Satoshi
    Ayuhara, Hideaki
    Takeuchi, Hironori
    Akahane, Daigo
    Gotoh, Akihiko
    Hori, Yusuke
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2025, 63 (01) : 30 - 37
  • [32] Ibrutinib-associated ventricular arrhythmia in the FDA Adverse Event Reporting System
    Cheng, Connie
    Woronow, Daniel
    Nayernama, Afrouz
    Wroblewski, Tanya
    Jones, S. Christopher
    LEUKEMIA & LYMPHOMA, 2018, 59 (12) : 3016 - 3017
  • [33] Adverse event reporting of faricimab: a disproportionality analysis of FDA adverse event reporting system (FAERS) database
    He, Chang-Zhu
    Qiu, Qin
    Lu, Song-Jie
    Xue, Fu-Li
    Liu, Jun-Qiao
    He, Yu
    FRONTIERS IN PHARMACOLOGY, 2025, 16
  • [34] Evaluation of spontaneous adverse event reports for anaemia attributed to atezolizumab within the FDA adverse events reporting system
    Zaafan, Ola
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 460 - 461
  • [35] Evaluation of Ticagrelor Bleeding Adverse Event Reports Compared to Clopidogrel in the FDA Adverse Events Reporting System (FAERS)
    Fahmy, Ahmed I.
    Mekkawy, Mohamed A.
    Abou-Ali, Adel
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 : 186 - 186
  • [36] Reports of adverse events related with second generation antipsychotics in children in the FDA adverse event reporting system (FAERS)
    Zapata, Lorenzo Villa
    Bibbs, Janese
    Crapps, Mariah
    Lumbreras, Ainhoa Gomez
    Malone, Daniel
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 579 - 580
  • [37] Evaluation of spontaneous adverse event reports for alopecia attributed to erenumab within the FDA adverse events reporting system
    Mekkawy, Mohamed
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 478 - 478
  • [38] Antibiotics-associated suicide between 1969 through 2005: An adverse event reports analysis using FDA and WHO databases
    Castilla-Puentes, R.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S228 - S228
  • [39] Updated insights into adverse events associated with mepolizumab: a disproportionality analysis from the FDA adverse event reporting system database
    Lin, Shan
    Luo, Dachen
    Gong, Zonglian
    Zhan, Qingyuan
    FRONTIERS IN MEDICINE, 2024, 11
  • [40] Fluoroquinolone-Associated Myasthenia Gravis Exacerbation Evaluation of Postmarketing Reports from the US FDA Adverse Event Reporting System and a Literature Review
    Jones, S. Christopher
    Sorbello, Alfred
    Boucher, Robert M.
    DRUG SAFETY, 2011, 34 (10) : 839 - 847
12345